Seed VC · Switzerland
Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats, striving to impact patients' lives by advancing innovative treatments for severe diseases.
Business models
biotech_therapeutics
Customer segments
Researchers
Geography
Europe, Switzerland, US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Pureos Bioventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Pureos Bioventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Pureos Bioventures is one of them, and we'll tell you exactly where they sit in your top 100.